Eden Bioscience (EDEN) to Deregister Common Stock & Liquidate

June 18, 2009 2:49 PM EDT

Eden Bioscience Corporation (NASDAQ: EDEN) has notified the NASDAQ Stock Market of its intent to voluntarily delist and deregister its common stock from The Nasdaq Capital Market. The Company has determined to voluntarily delist and deregister the Stock in connection with the recent approval by the Company's shareholders of a plan of complete dissolution and liquidation of the Company.

Prior to the open of the market on June 30, 2009, the Company will file with the Securities and Exchange Commission (the "SEC") and NASDAQ a Form 25 relating to the delisting and deregistration of the Stock. The Company expects that trading in the Stock will be permanently suspended by NASDAQ effective at the open of trading on June 30, 2009, with official delisting of the Stock becoming effective ten days thereafter, on July 10, 2009. The Company has not arranged for listing and/or registration of the Stock on another national securities exchange or for quotation in a quotation medium.

On June 18, 2009, the Company filed its articles of dissolution with the Secretary of State of the State of Washington and the Company will be dissolved as of 5:00 p.m., Pacific Time, on June 29, 2009 (the "Effective Time"). At the Effective Time, the Company will close its stock transfer books and discontinue recording transfers of shares of its Stock. After the Effective Time, certificates representing shares of Stock will not be assignable or transferable on the books of the Company except by will, intestate succession or operation of law. [SM]

Related Categories

Corporate News

Stocks Mentioned

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?